Revised - Consolidated and Standalone Unaudited Financial Results for the quarter and ninemonths ended December 31, 2025. The amount under one time deferred tax for the period under Nine Months ended 31st December, 2025 has been erroneously mentioned instead of Nil
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.1 pts more than its Fast Moving Consumer Goods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Godavari Biorefineries filed a revised version of its Q3 and 9M FY26 results on February 13, 2026, correcting an error in the earlier filing where a one-time deferred tax of Rs 2,450.01 lakhs was erroneously shown for 9M ended Dec 31, 2025 instead of Nil. Consolidated revenue from operations for Q3 FY26 stood at Rs 45,985.25 lakhs, up about 2.8% YoY, while the company reported a Q3 profit after tax of Rs 825.24 lakhs versus Rs 576.17 lakhs in Q3 FY25, a jump of roughly 43%. For the 9-month period, revenue grew about 10.3% YoY to Rs 1,42,383.96 lakhs, but the company remained in the red with a net loss of Rs 4,935.68 lakhs, though this is much narrower than the Rs 9,534.23 lakhs loss in 9M FY25. The 9M results include exceptional items of Rs 3,453.31 lakhs, comprising Rs 2,665.59 lakhs for additional sugarcane harvest charges and Rs 787.72 lakhs for the impact of new labour codes. The Distillery and Bio-based Chemicals segments showed strong revenue and operating profit growth, while Sugar segment remains weak.
The revision cleans up a prior filing error and removes a one-time deferred tax credit that was incorrectly recognised, so the true 9M loss is now confirmed at Rs 4,935.68 lakhs. Q3 has swung to a healthy profit with strong PAT growth, and losses are narrowing meaningfully, suggesting operational improvement. However, the 9-month loss position and ongoing exceptional charges mean the stock story remains mixed in the near term.